145 related articles for article (PubMed ID: 11555006)
21. [Present aspects and problems regarding occupational bladder cancer due to exposure to aromatic amines].
Yamamura J
J UOEH; 1989 Dec; 11(4):495-504. PubMed ID: 2692109
[TBL] [Abstract][Full Text] [Related]
22. [An epidemiological study of the cancer morbidity in persons having industrial contact with carcinogenic amino compounds].
Bul'bulian MA
Vopr Onkol; 1991; 37(3):275-9. PubMed ID: 2031321
[TBL] [Abstract][Full Text] [Related]
23. Mortality and incidence of bladder cancer in benzidine-exposed workers in China.
Bi W; Hayes RB; Feng P; Qi Y; You X; Zhen J; Zhang M; Qu B; Fu Z; Chen M
Am J Ind Med; 1992; 21(4):481-9. PubMed ID: 1580253
[TBL] [Abstract][Full Text] [Related]
24. [A cohort study on the cancer experience among workers exposed to benzidine-derived dyes in Shanghai leather-tanning industry].
Chen JG
Zhonghua Yu Fang Yi Xue Za Zhi; 1990 Nov; 24(6):328-31. PubMed ID: 2099267
[TBL] [Abstract][Full Text] [Related]
25. [Cancer mortality of male workers exposed to benzidine and/or beta-naphthylamine].
Morinaga K; Yutani S; Hara I
Nihon Eiseigaku Zasshi; 1990 Oct; 45(4):909-18. PubMed ID: 2089166
[TBL] [Abstract][Full Text] [Related]
26. Studies on the relation between bladder cancer and benzidine or its derived dyes in Shanghai.
You XY; Chen JG; Hu YN
Br J Ind Med; 1990 Aug; 47(8):544-52. PubMed ID: 2393635
[TBL] [Abstract][Full Text] [Related]
27. Relationship between glutathione S-transferase M1 deficiency and urothelial cancer in dye workers exposed to aromatic amines.
Shinka T; Ogura H; Morita T; Nishikawa T; Fujinaga T; Ohkawa T
J Urol; 1998 Feb; 159(2):380-3. PubMed ID: 9649243
[TBL] [Abstract][Full Text] [Related]
28. Bladder cancer mortality of workers exposed to aromatic amines: an updated analysis.
Piolatto G; Negri E; La Vecchia C; Pira E; Decarli A; Peto J
Br J Cancer; 1991 Mar; 63(3):457-9. PubMed ID: 2003988
[No Abstract] [Full Text] [Related]
29. Multiple primary cancers following exposure to benzidine and beta-naphthylamine.
Morinaga K; Oshima A; Hara I
Am J Ind Med; 1982; 3(3):243-6. PubMed ID: 7171086
[TBL] [Abstract][Full Text] [Related]
30. Decrease of CD4-positive T lymphocytes in workers exposed to benzidine and beta-naphthylamine.
Araki S; Tanigawa T; Ishizu S; Minato N
Arch Environ Health; 1993; 48(4):205-8. PubMed ID: 8102843
[TBL] [Abstract][Full Text] [Related]
31. Risk for lung cancer in workers exposed to benzidine and/or beta-naphthylamine: a protocol for systematic review and meta-analysis.
Tomioka K; Saeki K; Obayashi K; Tanaka Y; Kurumatani N
Syst Rev; 2014 Oct; 3():112. PubMed ID: 25281283
[TBL] [Abstract][Full Text] [Related]
32. Occupational reproductive function abnormalities and bladder cancer in Korea.
Park J; Shin KS; Kim Y
J Korean Med Sci; 2010 Dec; 25(Suppl):S41-5. PubMed ID: 21258590
[TBL] [Abstract][Full Text] [Related]
33. Drake Chemical Workers' Health Registry Study: I. Notification and medical surveillance of a group of workers at high risk of developing bladder cancer.
Marsh GM; Leviton LC; Talbott EO; Callahan C; Pavlock D; Hemstreet G; Logue JN; Fox J; Schulte P
Am J Ind Med; 1991; 19(3):291-301. PubMed ID: 2008919
[TBL] [Abstract][Full Text] [Related]
34. The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts.
Rothman N; Hayes RB; Zenser TV; DeMarini DM; Bi W; Hirvonen A; Talaska G; Bhatnagar VK; Caporaso NE; Brooks LR; Lakshmi VM; Feng P; Kashyap SK; You X; Eischen BT; Kashyap R; Shelton ML; Hsu FF; Jaeger M; Parikh DJ; Davis BB; Yin S; Bell DA
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):979-83. PubMed ID: 8959320
[TBL] [Abstract][Full Text] [Related]
35. Cancer mortality and incidence among a cohort of benzidine and dichlorobenzidine dye manufacturing workers.
Rosenman KD; Reilly MJ
Am J Ind Med; 2004 Nov; 46(5):505-12. PubMed ID: 15490466
[TBL] [Abstract][Full Text] [Related]
36. A further cohort study of workers employed at a factory manufacturing chemicals for the rubber industry, with special reference to the chemicals 2-mercaptobenzothiazole (MBT), aniline, phenyl-beta-naphthylamine and o-toluidine.
Sorahan T; Hamilton L; Jackson JR
Occup Environ Med; 2000 Feb; 57(2):106-15. PubMed ID: 10711278
[TBL] [Abstract][Full Text] [Related]
37. Notification and risk assessment for bladder cancer of a cohort exposed to aromatic amines. III. Mortality among workers exposed to aromatic amines in the last beta-naphthylamine manufacturing facility in the United States.
Stern FB; Murthy LI; Beaumont JJ; Schulte PA; Halperin WE
J Occup Med; 1985 Jul; 27(7):495-500. PubMed ID: 4032086
[TBL] [Abstract][Full Text] [Related]
38. Aromatic amines and cancer.
Vineis P; Pirastu R
Cancer Causes Control; 1997 May; 8(3):346-55. PubMed ID: 9498898
[TBL] [Abstract][Full Text] [Related]
39. Exposure to aromatic amines and ras and c-erbB-2 overexpression in bladder cancer.
Novara R; Coda R; Martone T; Vineis P
J Occup Environ Med; 1996 Apr; 38(4):390-3. PubMed ID: 8925323
[TBL] [Abstract][Full Text] [Related]
40. Clinical study on occupational uroepithelial cancer in Wakayama City.
Ohkawa T; Fujinaga T; Doi J; Ebisuno S; Takamatsu M; Nakamura J; Kido R
J Urol; 1982 Sep; 128(3):520-3. PubMed ID: 7120557
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
